India, Oct. 9 -- The following biotech stocks reached a 52-week high on October 8, 2026, driven by catalysts such as reports of an upcoming acquisition or upcoming financial reports.
Pacira BioSciences Inc. (PCRX) Pacira BioSciences provides various non-opioid pain therapies, including the local anesthetic EXPAREL for the management of post-surgical pain, and ZILRETTA for the treatment of osteoarthritic knee pain. The company's stock soared over 44% to a new 52-week high of $36.46 on Thursday. On Thursday, Vitaris Inc. (VTRS) agreed to acquire the company for an aggregate equity value of $1.65 billion. The acquisition includes Pacira's commercial products and intellectual property related to non-opioid therapeutics. Additionally, Vitaris w...